CVS margins under pressure; tariff uncertainty grows
Supply Chain Pulse — 2026-02-25
CVS Health's latest earnings reveal margin pressures that could ripple through PBM contracts, while Trump's expanded tariff authority creates new uncertainty for medical device and pharmaceutical imports. Plus, hospital-at-home programs are getting a tech boost that could reshape how you think about remote care logistics.
Quick Hits
- AI companies partner to streamline prior authorization processes (Modern Healthcare)
- Health systems deploy tech to identify patients' social needs gaps (Modern Healthcare)
- EU halts US trade pact over Trump's global tariff uncertainty (Supply Chain Dive - Healthcare)
CVS Health grapples with high costs, strategic reset
CVS executives maintain confidence that new PBM legislation won't impact margins, even as the company faces mounting cost pressures across its integrated model. For supply chain leaders, this signals potential shifts in PBM pricing strategies and contract negotiations as CVS works to maintain profitability amid regulatory scrutiny.
CVS annual profit guidance misses Wall Street estimates
CVS's below-consensus profit guidance and Aetna's slight Medicare Advantage enrollment decline for 2026 reflect broader market pressures on integrated payers. This could translate to tighter formulary management and increased scrutiny on high-cost specialty drugs and medical devices in upcoming contract cycles.
De minimis still shelved after Supreme Court's tariff ruling
Trump's executive order maintains the suspension of de minimis exemptions while adjusting postal duty rates to match new global tariffs. Small medical device shipments and pharmaceutical samples that previously entered duty-free will now face increased costs, potentially impacting your procurement budget for testing supplies and emergency inventory.
Source: Supply Chain Dive - Healthcare
The emerging technology that could help hospital-at-home expand
Health systems are deploying staffing logistics platforms, remote monitoring devices, and even drones to scale hospital-at-home programs beyond current capacity constraints. This tech-enabled expansion could shift significant volumes of supplies and equipment from traditional inpatient settings to distributed home care logistics networks.
Manufacturers look for certainty following Supreme Court's tariff decision
Industry groups are pushing for targeted tariff approaches as manufacturers face uncertainty about which medical products will be affected by Trump's expanded trade authorities. Supply chain leaders should prepare for potential cost increases on imported medical devices and raw materials while the administration clarifies its approach.
Source: Supply Chain Dive - Healthcare
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe